Hypothyroidism is a cause of secondary hyperlipidaemia. This study investigates the frequency of biochemically diagnosed hypothyroidism and its relationship with plasma cholesterol concentration in apparently healthy people.
Introduction
Hypothyroidism is a treatable cause of secondary hyperlipidaemia'. The lipid profile usually seen is an increased total and low density lipoprotein (LDL) cholesterol, and the plasma triglycerides may also be increased'', Such a profile is likely to increase the risk of coronary heart disease (CHD)3.
With increasing numbers of people being screened for hyperlipidaemia it is important to know the approximate prevalence of asymptomatic hypothyroidism in men and women with a raised plasma cholesterol. Effective treatment of the thyroid disorder would be expected to result in cholesterol lowering in most of these people. Treatment with a strict diet, and particularly with lipid lowering drugs, before correction of the hypothyroidism would thus be inappropriate.
This study investigated the prevalence of biochemically diagnosed hypothyroidism and its relationship to plasma cholesterol concentration.
Methods

Participants
Over 3000 people under age 70 from all over the United Kingdom participated in a study on vegetarian diet (no meat, no fish) versus meat eatings. They had a venous blood specimen taken in their local surgery and sent to the central laboratory, and also completed a detailed health and diet questionnaire. Two hundred and seventy-two individuals with plasma cholesterol level exceeding 7 mmol/l, and no mention in their questionnaires of thyroid problems or hypothyroidism, were then matched (3 : 1) by sex, dietary habit and 5 year age group to individuals with a plasma cholesterol level below 4.1 mmol/l. These selections roughly represented the top and bottom 10% of the population distribution. A small random group of men and women were also selected from the whole pool of participants. Analysis of thyroxine (T 4 ) concentration and thyroid stimulating hormone (TSH) levels were performed on plasma specimens and if the results were outside the reference range (1-6 mIU/l for TSH, 70-140 nmol/l for T 4 ) , a second blood specimen was requested. T 4 , TSH, free T 4 and thyroid antibodies were then measured on this specimen. Participants were classified as biochemically hypothyroid if they had a TSH level exceeding 10 mIU/l and a total T 4 or free T 4 < 70 nmol/l or 10 pmol/l respectively.
Analytical methods
Total plasma cholesterol concentration and cholesterol in lipoprotein fractions was measured enzymatically using cholesterol oxidase on a Technicon Autoanalyser II using kits obtained by Boehringer Ltd. Lipoprotein subfractions were separated by chemical precipitation. In one aliquot very low density lipoprotein (VLDL) and low density lipoprotein (LDL) were precipitated by heparin/manganese'', and the high density (HDL) cholesterol in the supernatant measured. In another aliquot VLDL was precipitated with sodium dodecylsulphate", The quantity of cholesterol in the various subfractions was then calculated by subtraction.
T 4 and TSH concentrations were measured by radioimmunoassay, using an 125I-Iabelled antigen and antibody obtained from Biogenesis Ltd, and Bioclinical Services, Cardiff, respectively. Free T 4 was measured using coated tube technology in kits obtained from Diagnostic Products Corporation. Thyroid microsomal antibodies were measured by coated gelatin particle agglutination using Serodia AMC kits from Fujirebio Inc (Mast Diagnostics).
Statistical analysis was performed using Fisher's exact test.
Results
Overall, 3277 people (1198 meat eaters and 2079 nonmeat eaters) were used as the study base population in this opportunistic investigation. The mean plasma cholesterol level of the vegetarians was 5.4±1.0 and of the meat eaters 5.9±1.3 mmol/l. Two hundred Overall 5.9% of those with a cholesterol level exceeding 7 mmolll had biochemical evidence of hypothyroidism. This comprised 9/179 (5.02%) of the vegetarians with a cholesterol in this range and 7/93 (7.53%) of the meat eaters, and was not significantly different in these two groups. The characteristics and laboratory values for these individuals are presented in Table 1 . One of the men in the 'vegetarian' group was in fact a vegan. Most of the people had high LDL levels, but the women had high HDL cholesterols (reference range 1.2-1.75 mmolll for women) with six having concentrations > 2 mmol/l. Twelve of these people (nine women, three men) had raised thyroid microsomal antibodies at a titre of 1 in 400 or greater, whereas the frequency of antibodies at that titre in the general population is less than 8%. Eight had a plasma cholesterol exceeding 8 mmol/l. Of the total 83 people from the population screened who had a plasma cholesterol above 8 mmolll, these eight had biochemical hypothyroidism, two had borderline results and 73 had all values within the reference range.
A further 10 individuals in the hypercholesterolaemic group (five vegetarian) had thyroid function tests which could be considered borderline (T 4 70-80 nmolll and TSH of6-1O mIUIl) indicating that they could be developing hypothyroidism. Examination of the health questionnaires on people with abnormal results did not reveal any specific clinical symptomatology. The number of abnormal or borderline results was not significantly different in the vegetarians and the meat eaters. The group of 25 people selected at random (15 vegetarian) had a mean cholesterol level similar to the base population, and only one had a borderline TSH of 6 mIUIl, a T 4 of 78 nmolll and a thyroid antibody titre of 1 in 1600: she had a plasma cholesterol of 6.8 mrnol/l. None of the 90 individuals with a plasma cholesterol level below 4.1 mmolll who were age/sex matched with the high cholesterol group had biochemical evidence of hypothyroidism. One woman had a raised TSH of 16 mIUIl but her free T 4 was within the reference range.
The incidence of biochemical hypothyroidism, and of 'borderline' results was thus significantly higher in people with cholesterol levels exceeding 7 or 8 mmolll (P<O.OI, P<0.05, Fisher's exact test).
Discussion
It is well known that hypothyroidism results in a rise in circulating LDL and total cholesterol levels'. It may also cause hypertriglyceridaemia despite the fact that the supply of fatty acid to the liver is reduced by the reduction in adipose tissue lipolysis. Hypothyroidism may also result in a 'broad beta' lipoprotein pattern if it occurs in genetically disposed people'. The reasons for these findings are related to the effects of thyroid hormones on lipoprotein metabolism. Thyroid hormones enhance the intravascular catabolism of VLDL triglyceride", and lower plasma cholesterol and LDL concentrations -a response probably explained by the hormones effects on receptor-mediated uptake and catabolism of LDL9. Triiodothyronine, T a , promotes the binding and subsequent degredation of LDL by cultured human fibroblasts'", The hepatic excretion of cholesterol and its conversion to bile acids is also increased by thyroid hormones". HDL is influenced by thyroid hormones due to the effects on enzyme activity and the metabolism of HDL apoproteins!'. HDL cholesterol concentrations increase in hypothyroidisrrr'. Levels were certainly high in most of the hypothyroid women found in our study.
In general, the severity of the lipid abnormality does not parallel the degree of hypothyroidism, and it would seem this was the case in our hypothyroid group. It has also been demonstrated that hypercholesterolaemia can in fact precede all evidence of thyroid failure in people with autoimmune thyroiditis who later develop biochemical and clinical evidence of hypothyroidism", The incidence of hypothyroidism in the population is age and sex related -being commoner in women and in the older age group, but the prevalence of asymptomatic disease is unclear. The Glasgow series of apparently healthy blood donors suggested that overall it was probably under 2%12. Our random group is not large enough to confirm this for our particular population. It is however noteworthy that 6% of individuals with a plasma cholesterol level > 7 mmol/l had hypothyroidism on biochemical testing. Their age was not significantly greater, and threequarters were women, conforming with the usual sex distribution of clinical hypothyroidism. Most had thyroid microsomal antibodies -some at very high titres -indicating that the aetiology was probably autoimmune. Only one of the random group had antibodies at a titre above 1 in 400, and this could be expected, as a low positive antibody titre occurs in about 8% of a well population.
The prevalence of hypothyroidism was greater in those with a cholesterol >8mmol/l (10%), but there were still eight people with biochemical hypothyroidism and eight with borderline results in the 189 with cholesterols between 7 and 8 mmol/l. This seems higher than that found in the smaller group documented by Series et al. 12 • Two disadvantages of this study are the small randomly selected group and the lack of follow-up. Thyroid hormone analysis was repeated after several months, but may not have excluded a transient disorder. The original study of measuring cholesterol levels in vegetarians and meat eaters was not a follow-up study and we could only obtain results post-thyroxine treatment on two patients, both of whom experienced a 30% cholesterol lowering. Thus we cannot show that treatment with thyroxine, if clinically warranted, always improves the lipid profile, and are aware that some patients may have biochemical hypothyroidism but another cause for their hyperlipidaemia. The study does, however, look at people from a large geographical area, and includes people who take a diet which excludes meat and fish. It provides the interesting indication that biochemical hypothyroidism is no commoner in vegetarians, although this was not the main point of the study and has not been investigated further with respect to quantitative examination of nutrient intake.
The main finding of the study is the relatively high incidence of apparently unsuspected and asymptomatic hypothyroidism in people with hypercholesterolaemia. Some of the cases may have been obvious clinically to an expert, but it is likely that others would not have been, or would not have been seen by such. It raises the issue of the need to exclude hypothyroidism, probably by laboratory analysis, in patients with hypercholesterolaemia prior to embarking on longterm treatment with costly lipid lowering drugs. Many years ago raised cholesterol was used as a test to diagnose likely hypothyroidism. This could be misleading, as there are obviously so many other causes of hypercholesterolaemia, but hypothyroidism may now in fact be under considered as a cause or an Journal of the Royal Society of Medicine Volume 84 September 1991 529 accentuating factor. Many people with hypothyroidism, particularly older people, do not have symptoms or signs suggesting the condition, so questioning and clinical examination do not exclude the disorder.
Hypercholesterolaemia secondary to hypothyroidism increases the CHD risk. It is also interesting that thyroid antibodies are commoner in people with CHD than in the general population!", and that there are also significant associations between thyroid antibodies, obesity, hypertension and diabetes.
In conclusion, hypothyroidism is reasonably common in people with significant hypercholesterolaemia. It is eminently treatable and this could well result in lipid lowering. It is therefore important that the situation is documented further in large studies specifically designed to screen, manage and followup people with hyperlipidaemia.
